Navigation Links
New research shows lower educational outcomes for survivors of childhood cancer
Date:4/1/2009

VANCOUVER, APRIL 1, 2009 New research funded by the Canadian Cancer Society has discovered poor educational achievement and learning difficulties for some childhood cancer survivors, especially those diagnosed with brain tumours. This first-of-its-kind study, published in the journal Cancer, raises critical questions about the long term outlook for children with cancer.

"These are very significant findings," says Barbara Kaminsky, CEO Canadian Cancer Society BC and Yukon. "It is not good enough to just improve survival rates for these children. We need to ensure that as many childhood cancer patients as possible become more than survivorsrather we hope to have post-cancer thrivers."

Advances in treatment have dramatically increased the survival rate to over 80 per cent for children diagnosed with cancer. This has resulted in a growing number of children in today's education system who are cancer survivors. Unfortunately, many childhood cancer survivors suffer what are known as "adverse late effects" problems that may be related to the disease itself or the aggressive treatments they have been through.

With funding from the Canadian Cancer Society, this study is one of a series of papers expected from Mary McBride, senior scientist at the BC Cancer Agency and primary investigator for the Childhood Adolescent and Young Adult Cancer Survivors Research program (CAYACS).

Parents and teachers have reported educational difficulties among survivors. Cancer survivors achieve lower levels of education, increased utilization of special education services and are more likely to repeat a grade level.

There is considerable evidence of adverse late effects including lower intelligence testing scores that may impact educational performance. A number of factors that increase the risk of poorer educational outcomes include diagnosis or treatment at a younger age, specific therapies and certain types of treatment. Girls
'/>"/>

Contact: Kristine Carrick
kcarrick@bc.cancer.ca
604-675-7340
Canadian Cancer Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... Traditional healthcare,s uncertain future and ...lternative care. Affordable Acupuncture Scottsdale...EB) November 29, 2009 -- Affordable Acupuncture, L...) and has been met with enthusiasm and gratitude. ... attributed to two things, need and cost. "A...
(Date:11/28/2009)...help lift spirits, recognize signs of depression ,... For many seniors, the holiday season can trigger ...ruggle with health issues or worry about money pro...y. , To help overcome the seasonal blues, the A...wing advice: , Get out and socialize or invite f...
(Date:11/27/2009)...CO, Nov. 27 The Gymboree... Lambert, CFO/COO, will present at the NASDAQ OMX ...ay Fair Hotel in London, England, on Wednesday, De... to a live broadcast of The Gymboree Corporation,s...www.gymboree.com, click on "Our Company" at the bo...
(Date:11/27/2009)...us low-emission vehicles may reduce future disease.... 27 (HealthDay News) -- Encouraging city dwellers...ffer much greater public health benefits than incr...ers have found. , The study compared the projec...nd transport scenarios for London, England, and De...
(Date:11/27/2009)... Specialist manufacturers who use medical load ...llions of dollars by bringing in technology partne...numbers of pro-active medical manufacturers are ca...stage of their projects, ensuring that progress wi... or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...on , , SATURDAY, Nov. 29 (HealthDay News) ...afe, itch and develop dry patches, but there are a... says Jeff Moore, an instructor of pharmaceutics a... infection," Moore said in a university news relea...
... /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (N...hairman and Chief Executive Officer, Bob Rieder, w... 45,000 common shares from his direct holding of C...uch an inopportune time; however the global financ...
...obal observance of World AIDS Day, a time during w...rage of the 33 million people living with and affe...e to remember those whose lives,have been lost. I...cy Plan for AIDS Relief (PEPFAR/Emergency Plan), t...
...Inc. (Nasdaq: STRM ) announced today it will rel...scal year 2008 ended October 31, 2008 on Monday, D...rence call and webcast to discuss,the results on M...necessary audit work to finalize the results. , ...
...rfect,holiday gift? Maybe it,s time to help your ...thier smile. , , Listen to this report from P...story=36013 , , Registered journalists can a... at http://www.mediaseed.tv . , 11NY08-0055...
...S Day on Monday, December 1, the Global AIDS Allia...n to intensify the US effort against HIV/AIDS, bot..." , , Over 100 global health advocacy organiz...mo is online: , , http://www.globalaidsallia...
Other Medicine News:Health News:Dry Skin? Don't Let Winter Win 2Health News:Cardiome Discloses Chairman And CEO's Involuntary Share Sale 2Health News:Cardiome Discloses Chairman And CEO's Involuntary Share Sale 3Health News:From USAID Administrator, Henrietta H. Fore: Renewed Commitment On World AIDS Day 2Health News:Streamline Health Reschedules Q3 Financial Results Release and Conference Call for Monday, December 15, 2008 2Health News:World AIDS Day December 1st: Obama Needs to Lead 2
(Date:11/29/2009)... FUJIFILM Medical Systems USA, Inc. is pleased to ...l DR cassette, at the 2009 Radiological Society of...ny clinical environment, FDR D-EVO uses an innovat...film,s trademark image quality and outstanding fle...o transition to DR without modification to the exa...
(Date:11/29/2009)... Researchers using functional magnetic resonance i... that men and women respond differently to positiv...nted today at the annual meeting of the Radiologic... direct more attention to sensory aspects of emoti...implications for required action, whereas women di...
(Date:11/27/2009)...swire/ -- ACUO TECHNOLOGIES, developers of high-pe...migration tools and services, is pleased to announ...ice has approved a patent application for an "Asse... Acuo Technologies is pleased to add the U.S. pate...eneral, the granted patent application broadly pro...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 1Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 2Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 1Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 2Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 4Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 5Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 6Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 7Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 1Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 2
...AN FRANCISCO, June 9 Halozyme Therapeutics,Inc. (...oping and,commercializing products targeting the e...ata for the company,s diabetes mellitus program at...ic Sessions. The data,showed that combining the co...e enzyme (rHuPH20) with Humulin R(R) (regular insu...
...SPIRE IRB Is Exhibiting at Bio International Conve... 17-20, Currently, over 54,255 Trials with L... Place, SAN DIEGO, June 9 ASPI...nt Review Board (IRB), is,responsible for overseei...of people participating in clinical trials. ASPIRE...
Other Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 2ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 3
Penicillin-Streptomycin Mixture
PEN-STREP, 100X
Gentamicin, 10 mg/ml
GENTAMICIN SULFATE, 1000X
Medicine Products: